Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy.
J Clin Exp Hematop. 2024;64(2):107-118. doi: 10.3960/jslrt.24009.
J Clin Exp Hematop. 2024.
PMID: 38925972
Free PMC article.
Clinical outcomes in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma after second-line salvage chemotherapy: A retrospective study.
Yagi Y, Kanemasa Y, Sasaki Y, Sei M, Matsuo T, Ishimine K, Hayashi Y, Mino M, Ohigashi A, Morita Y, Tamura T, Nakamura S, Okuya T, Shimizuguchi T, Shingai N, Toya T, Shimizu H, Najima Y, Kobayashi T, Haraguchi K, Doki N, Okuyama Y, Shimoyama T.
Yagi Y, et al. Among authors: ishimine k.
Cancer Med. 2023 Sep;12(17):17808-17821. doi: 10.1002/cam4.6412. Epub 2023 Aug 28.
Cancer Med. 2023.
PMID: 37635630
Free PMC article.
Item in Clipboard
Hemoglobin-platelet index as a prognostic factor in patients with peripheral T-cell lymphoma.
Yagi Y, Kanemasa Y, Sasaki Y, Okumura S, Watanabe T, Ishimine K, Hayashi Y, Mino M, Ohigashi A, Morita Y, Tamura T, Nakamura S, Okuya T, Shimoyama T.
Yagi Y, et al. Among authors: ishimine k.
EJHaem. 2023 May 26;4(3):656-666. doi: 10.1002/jha2.727. eCollection 2023 Aug.
EJHaem. 2023.
PMID: 37601871
Free PMC article.
Item in Clipboard
[Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant].
Morita Y, Yagi Y, Kanemasa Y, Sasaki Y, Ishimine K, Hayashi Y, Mino M, Ohigashi A, Tamura T, Nakamura S, Okuya T, Shimizuguchi T, Shingai N, Toya T, Shimizu H, Najima Y, Kobayashi T, Haraguchi K, Doki N, Okuyama Y, Ohashi K, Shimoyama T.
Morita Y, et al. Among authors: ishimine k.
Rinsho Ketsueki. 2023;64(7):586-595. doi: 10.11406/rinketsu.64.586.
Rinsho Ketsueki. 2023.
PMID: 37544717
Japanese.
Item in Clipboard
Utility of the frailty score for predicting prognosis and individualizing treatment intensity in elderly patients with diffuse large B cell lymphoma.
Yagi Y, Kanemasa Y, Sasaki Y, Goto S, Yamamura Y, Ishimine K, Hayashi Y, Mino M, Ohigashi A, Morita Y, Tamura T, Nakamura S, Okuya T, Shimoyama T.
Yagi Y, et al. Among authors: ishimine k.
Ann Hematol. 2023 Jun;102(6):1485-1500. doi: 10.1007/s00277-023-05233-2. Epub 2023 Apr 28.
Ann Hematol. 2023.
PMID: 37115298
Item in Clipboard
Assessing the effectiveness of Australian early childhood education and care experiences: study protocol.
Tayler C, Cloney D, Adams R, Ishimine K, Thorpe K, Nguyen TK.
Tayler C, et al. Among authors: ishimine k.
BMC Public Health. 2016 Apr 21;16:352. doi: 10.1186/s12889-016-2985-1.
BMC Public Health. 2016.
PMID: 27098954
Free PMC article.
Item in Clipboard
Cite
Cite